Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling
Alan M. Sandercock(AstraZeneca (United Kingdom)), Ralph Minter(AstraZeneca (United Kingdom))
Cited by 53
Related Papers
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
|Nature Communications|2017|106
Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening
|Nature Biomedical Engineering|2023|74